Holen Sie sich die Stockscreener-App
14.93
6.72%
0.94
Handel nachbörslich:
14.70
-0.23
-1.54%
Schlusskurs vom Vortag:
$13.99
Offen:
$13.83
24-Stunden-Volumen:
788.32K
Relative Volume:
0.70
Marktkapitalisierung:
$1.06B
Einnahmen:
$133.62M
Nettoeinkommen (Verlust:
$-177.37M
KGV:
-5.1661
EPS:
-2.89
Netto-Cashflow:
$23.50M
1W Leistung:
+7.41%
1M Leistung:
+20.11%
6M Leistung:
+83.42%
1J Leistung:
-36.47%
1-Tages-Spanne:
$13.73
$15.09
1-Wochen-Bereich:
$13.57
$15.29
52-Wochen-Spanne:
$6.92
$27.24
Xencor Inc Stock (XNCR) Company Profile
Firmenname
Xencor Inc
Sektor
Branche
Telefon
626-305-5900
Adresse
465 N. HALSTEAD ST., PASADENA, CA
Vergleichen Sie XNCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
14.93 | 999.03M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-29 | Hochstufung | Barclays | Underweight → Overweight |
| 2025-09-17 | Fortgesetzt | Barclays | Underweight |
| 2025-09-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-04-21 | Eingeleitet | William Blair | Outperform |
| 2024-12-12 | Eingeleitet | Wells Fargo | Overweight |
| 2024-12-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | Bestätigt | BTIG Research | Buy |
| 2024-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | Eingeleitet | BofA Securities | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-10-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | Eingeleitet | JP Morgan | Overweight |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-11 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-01-21 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-02-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | Eingeleitet | Barclays | Underweight |
| 2020-02-25 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-01-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-11-20 | Fortgesetzt | Guggenheim | Neutral |
| 2019-08-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-08-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | Eingeleitet | Mizuho | Buy |
| 2019-04-12 | Eingeleitet | Guggenheim | Buy |
| 2019-03-27 | Eingeleitet | Berenberg | Buy |
| 2019-03-15 | Eingeleitet | Raymond James | Outperform |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-03-28 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-03-02 | Eingeleitet | Instinet | Neutral |
| 2017-03-02 | Bestätigt | Wedbush | Outperform |
| 2016-10-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-12-22 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-05 | Bestätigt | MLV & Co | Buy |
| 2015-02-12 | Bestätigt | Oppenheimer | Outperform |
| 2015-01-28 | Bestätigt | MLV & Co | Buy |
| 2014-07-11 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Xencor Inc Aktie (XNCR) Neueste Nachrichten
Is Xencor Inc. (XE9) stock undervalued historicallyJuly 2025 Levels & Real-Time Buy Signal Alerts - newser.com
Why Xencor Inc. stock remains on buy listsDip Buying & Fast Momentum Stock Entry Tips - newser.com
Should you hold or exit Xencor Inc. nowWeekly Trade Report & Weekly Breakout Watchlists - newser.com
What candlestick patterns are forming on Xencor Inc.Market Rally & Verified Momentum Stock Watchlist - newser.com
What to expect from Xencor Inc. in the next 30 days2025 Investor Takeaways & Target Return Focused Picks - newser.com
Los Angeles Capital Management LLC Purchases 83,143 Shares of Xencor, Inc. $XNCR - MarketBeat
Tick level data insight on Xencor Inc. volatilityQuarterly Trade Report & Expert Verified Stock Movement Alerts - newser.com
Can Xencor Inc. stock continue upward trendMarket Activity Report & Safe Investment Capital Preservation Plans - newser.com
Is Xencor Inc. (XE9) stock nearing a technical breakoutJuly 2025 Opening Moves & Technical Pattern Alert System - newser.com
Why analysts remain bullish on Xencor Inc. stock2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com
How Xencor Inc. stock compares to growth peersGold Moves & High Accuracy Investment Signals - newser.com
Does Xencor’s Sharply Reduced Loss in Q3 2025 Signal a Turnaround for XNCR? - simplywall.st
How Xencor Inc. (XE9) stock benefits from digital adoptionQuarterly Trade Review & Accurate Technical Buy Alerts - newser.com
Xencor (XNCR): Assessing Valuation After Net Losses Narrow Sharply in Latest Earnings - Yahoo Finance
Will Sharply Reduced Net Losses Signal a Turning Point for Xencor's (XNCR) Path to Profitability? - Yahoo Finance
Can a trend reversal in Xencor Inc. lead to recoveryTrade Volume Summary & Verified Technical Trade Signals - newser.com
Xencor (NASDAQ:XNCR) Shares Up 8.7%What's Next? - MarketBeat
Xencor at TD Cowen Summit: Strategic Focus on Oncology and Autoimmune - Investing.com Nigeria
Xencor Inc. stock trend forecastWeekly Trend Recap & Capital Efficient Trade Techniques - newser.com
Will Xencor Inc. (XE9) stock return to pre crash levelsJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
Positive readouts validate pipelines, fuel drug developer rally - BioWorld MedTech
Why institutional investors increase stakes in Xencor Inc. (XE9) stockJuly 2025 Big Picture & Low Drawdown Trading Techniques - newser.com
Xencor to Participate at Upcoming Investor Conferences - Business Wire
Is Xencor Inc. stock gaining market shareRate Cut & Free Weekly Watchlist of Top Performers - newser.com
Cantor Fitzgerald Predicts Increased Earnings for Xencor - MarketBeat
Wedbush Estimates Xencor's FY2025 Earnings (NASDAQ:XNCR) - MarketBeat
FY2025 Earnings Estimate for Xencor Issued By William Blair - MarketBeat
Leerink Partnrs Increases Earnings Estimates for Xencor - MarketBeat
Published on: 2025-11-09 23:13:10 - newser.com
Can volume confirm reversal in Xencor Inc.2025 Momentum Check & Daily Stock Momentum Reports - newser.com
Xencor (NASDAQ:XNCR) Price Target Cut to $18.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
Wedbush Reaffirms "Outperform" Rating for Xencor (NASDAQ:XNCR) - MarketBeat
Xencor (NASDAQ:XNCR) Given New $19.00 Price Target at Royal Bank Of Canada - MarketBeat
Xencor (NASDAQ:XNCR) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
Tools to assess Xencor Inc.’s risk profileWeekly Market Summary & Target Return Focused Stock Picks - newser.com
Xencor (XNCR) Gets a Hold from Bank of America Securities - The Globe and Mail
Finanzdaten der Xencor Inc-Aktie (XNCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):